NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,952 | +5.3% | 3,082 | +4.3% | 0.26% | +5.8% |
| Q2 2023 | $298,107 | +12.3% | 2,954 | +2.4% | 0.24% | +4.3% |
| Q1 2023 | $265,530 | +7.9% | 2,886 | +6.4% | 0.23% | -3.3% |
| Q4 2022 | $246,123 | +20.1% | 2,713 | +0.4% | 0.24% | +10.6% |
| Q3 2022 | $205,000 | -10.5% | 2,702 | -0.4% | 0.22% | -3.6% |
| Q2 2022 | $229,000 | -4.6% | 2,712 | -0.7% | 0.22% | +16.0% |
| Q1 2022 | $240,000 | +2.1% | 2,732 | +1.8% | 0.19% | +6.6% |
| Q4 2021 | $235,000 | +11.9% | 2,683 | +4.6% | 0.18% | +2.8% |
| Q3 2021 | $210,000 | -10.3% | 2,565 | +0.2% | 0.18% | -8.8% |
| Q2 2021 | $234,000 | +8.3% | 2,560 | +1.3% | 0.19% | +0.5% |
| Q1 2021 | $216,000 | -11.8% | 2,526 | -3.7% | 0.19% | -17.2% |
| Q4 2020 | $245,000 | – | 2,622 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |